Navigation Links
UT Dallas researchers find early success in new treatment for stroke recovery
Date:10/1/2013

Researchers at The University of Texas at Dallas have taken a step toward developing a new treatment to aid the recovery of limb function after strokes.

In a study published online in the journal Neurobiology of Disease, researchers report the full recovery of forelimb strength in animals receiving vagus nerve stimulation.

"Stroke is a leading cause of disability worldwide," said Dr. Navid Khodaparast, a postdoctoral researcher in the School of Behavioral and Brain Sciences and lead author of the study. "Every 40 seconds, someone in the U.S. has a stroke. Our results mark a major step in the development of a possible treatment."

Vagus nerve stimulation (VNS) is an FDA-approved method for treating various illnesses, such as depression and epilepsy. It involves sending a mild electric pulse through the vagus nerve, which relays information about the state of the body to the brain.

Khodaparast and his colleagues used vagus nerve stimulation precisely timed to coincide with rehabilitative movements in rats. Each of the animals had previously experienced a stroke that impaired their ability to pull a handle.

Stimulation of the vagus nerve causes the release of chemicals in the brain known to enhance learning and memory called neurotransmitters, specifically acetylcholine and norepinephrine. Pairing this stimulation with rehabilitative training allowed Khodaparast and colleagues to improve recovery.

Many rehabilitative interventions try to enhance neuroplasticity (the brain's ability to change) in conjunction with physical rehabilitation to drive the recovery of lost functions, according to Khodaparast. Unfortunately, up to 70 percent of stroke patients still display long-term impairment in arm function after traditional rehabilitation.

"For years, the majority of stroke patients have received treatment with various drugs and/or physical rehabilitation," Khodaparast said. "Medications can have widespread effects in the brain and the
'/>"/>

Contact: Ben Porter
ben.porter@utdallas.edu
972-883-2193
University of Texas at Dallas
Source:Eurekalert

Page: 1 2

Related biology news :

1. UT Dallas researchers pushing the boundaries of virtual reality
2. UT Dallas researchers awarded $4.3 million to create next-generation technologies
3. University of Utah researchers receive NIH Directors New Innovator Award
4. UC Davis researchers discover a biological link between diabetes and heart disease
5. Researchers use smart phone photography to diagnose eye disease
6. University of Maryland researchers studying vaccine to prevent potential bird flu pandemic
7. Clemson researchers: Different forage affects beef cattle weight, taste
8. New HIV-1 replication pathway discovered by NYU College of Dentistry researchers
9. Rensselaer researchers create accurate computer model of RNA tetraloop
10. Researchers hit virtual heads to make safer games
11. UAlberta medical researchers discover how immune system kills healthy cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2015)... 2015 The biologics safety testing market is ... the market include growth of the pharmaceutical and biological ... Over the years, the number of drug approvals in ... the FDA approved 225 drug applications and Health Canada ... Europe accounted for 3,822 of the pharmaceutical ...
(Date:6/24/2015)... 22, 2015 Research ... of the "Huawei Ascend Mate 7 Fingerprint ... their offering. Huawei,s technological choice for ... direction than Apple,s and Samsung,s one. The Ascend ... by Fingerprint Cards, a main actor in capacitive ...
(Date:6/23/2015)... DUBLIN , June 22, 2015 ... has announced the addition of the "Body-Worn ... Share, Growth, Trends and Forecast 2014 - 2020" ... report offers strategic analysis of the global body-worn ... market has been segmented on the basis of ...
Breaking Biology News(10 mins):Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 3Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 4Huawei Ascend Mate 7 Fingerprint Sensor - Reverse Costing Analysis 2Body-Worn Temperature Sensors Market - Global Industry Analysis 2
... was recently discovered in the cloud-forests of Peru. The large ... a bit like one, except its closest relatives are spiny ... yet strange looking, with long dense fur, a broad blocky ... on the crown, nape and shoulders add to its distinctive ...
... Washington University School of Medicine in St. Louis, living ... Then, because of the unusual meal, the cells were ... mice. , Developed in the laboratories of Samuel ... nanoparticles could soon allow researchers and physicians to directly ...
... to develop a quick, simple and cheap immune-system test for ... in the poorest countries get appropriate treatment to extend their ... , The work is part of an $8.6 million international ... London and funded by the Bill and Melinda Gates Foundation. ...
Cached Biology News:Scientists discover new species of distinctive cloud-forest rodent 2Nanoparticles can track cells deep within living organisms 2Nanoparticles can track cells deep within living organisms 3Cornell researcher helping develop quick, cheap HIV/AIDS test 2
(Date:7/1/2015)... Colo. and BANGALORE, India ... global genomic profiling company that uses next generation sequencing ... of Scott A. Storrer as chief executive ... CEO, he will be responsible for all strategy, business ... Chandru , who has served as Strand,s chairman and ...
(Date:7/1/2015)... , July 1, 2015 InferMed ... technology will ... evidence-based clinical s olutions suite   ... and medical information products and services, announced today the acquisition ... decision support (CDS) technology company. InferMed,s Arezzo technology ...
(Date:6/30/2015)... ... June 30, 2015 , ... Students and faculty ... the first half of “Integrative Biotechnology,” an applied biotechnology course team-taught by faculty ... this course combines students from both universities and is taught on both continents. ...
(Date:6/30/2015)... -- Today, Americord Registry, one of the fastest growing cord blood ... partner at Kirkland & Ellis LLP, as the newest member ... http://photos.prnewswire.com/prnh/20150630/226958LOGO   "We are thrilled about Andrew ... Smithmyer , CEO of Americord. "He brings a wealth of ... Americord,s growth and vision." Andrew Horne ...
Breaking Biology Technology:Strand Life Sciences Names Scott A. Storrer CEO as Company Continues Global Expansion with Focus on Precision Medicine Product 2Strand Life Sciences Names Scott A. Storrer CEO as Company Continues Global Expansion with Focus on Precision Medicine Product 3Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 2Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 3Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 4Rivier University and Beijing City University Academic and Cultural Exchanges Begin 2Americord Registry Announces Andrew Horne as Advisory Board Member 2
... patients with cutaneous T-cell lymphoma on schedule for completion ... June 29 Yaupon Therapeutics, a privately held specialty ... a pivotal Phase 2 clinical trial for Clearazide for ... stages 1-2a). The study, which is being conducted ...
... , PRINCETON, N.J., June 29 DOR ... (OTC Bulletin Board: DORB), a late-stage biopharmaceutical company, announced ... Center, Seattle, Washington, published a paper this morning in ... that DOR,s lead product orBec(R) (oral beclomethasone dipropionate or ...
... - YM BioSciences Inc. (NYSE Amex: YMI ... company that identifies and advances a diverse portfolio ... development, today reported that YM,s subsidiary, CIMYM BioSciences ... between the companies in a cooperative effort. CIMYM ...
Cached Biology Technology:Yaupon Therapeutics Completes Patient Enrollment for Pivotal Phase 2 Study of Clearazide for Treatment of Cutaneous T-cell Lymphoma 2DOR BioPharma Announces Publication of orBec(R) Clinical Pulmonary Data in Bone Marrow Transplantation 2DOR BioPharma Announces Publication of orBec(R) Clinical Pulmonary Data in Bone Marrow Transplantation 3DOR BioPharma Announces Publication of orBec(R) Clinical Pulmonary Data in Bone Marrow Transplantation 4DOR BioPharma Announces Publication of orBec(R) Clinical Pulmonary Data in Bone Marrow Transplantation 5DOR BioPharma Announces Publication of orBec(R) Clinical Pulmonary Data in Bone Marrow Transplantation 6YM BIOSCIENCES' SUBSIDIARY RESOLVES PROPOSED ARBITRATION WITH ONCOSCIENCE AG 2YM BIOSCIENCES' SUBSIDIARY RESOLVES PROPOSED ARBITRATION WITH ONCOSCIENCE AG 3YM BIOSCIENCES' SUBSIDIARY RESOLVES PROPOSED ARBITRATION WITH ONCOSCIENCE AG 4
SAPK/JNK Antibody...
Mouse monoclonal [DJR3] to DcR1 (Biotin) ( Abpromise for all tested applications). entrezGeneID: 8794 SwissProtID: O14798...
Tris-EDTA Buffer Solution, 1X, pH 8.0, sterile, Molecular Biology Grade...
Component in MasterPure™ Purification Kits...
Biology Products: